Sorrento Therapeutics Inc (SRNE)

[HeadsIwin]

Impressive to say the least:
• Funded and Operational in 2009.
• NASDAQ: SRNE.
• HQ in San Diego, CA.
~800 Employees worldwide.
~120 Employees with PhDs & MDs.
~500,000 SF Research and cGMP Manufacturing Facilities.
• 8 Manufacturing Sites (5 USA, 3 China)
mAbs, Small Molecule, ADC, Plasmid DNA, mRNA, Cell Therapies,
Diagnostics, Oncolytic Viruses, Lymphatic Drug Delivery,
and Fill & Finish.
• FDA Approved Drugs
ZTlido® (lidocaine topical system) 1.8%, Gloperba® for Gout
• EUA Approved Diagnostic Test in Mexico, Brazil and CE Mark Registered.
COVISTIXTM COVID-19 Virus Rapid Antigen Detection Test.
• Multiple Products in Late-Stage Clinical Development.
Focused on Pain Management, Immune-Oncology and COVID-19